Over 15 lakh ‘virgin voters’ set to exercise franchise in Karnataka polls

Bengaluru, Feb 10: Senior Congress leader DK Shivakumar on Sunday hit out at the BJP and RSS for taking out a route march in Ramanagara against the controversial Jesus Christ statue.

“Just because the BJP won 25 seats in the Lok Sabha polls, Congress workers need not lose hope. If the Congress and JD(S) had worked out a better strategy, the BJP would not have won even 10 seats. We will correct our mistakes,” the former Congress minister said.

After the Lok Sabha polls, the BJP has failed to do well in assembly polls and has been losing power in many states. People are hitting the streets protesting against its policies such as CAA and NRC, he said.

Accusing the BJP and RSS of not being able to digest Congress’ victory in the Bengaluru Rural Lok Sabha segment in the 2019 Lok Sabha polls, he said that the BJP is trying hard to make inroads into the constituency represented by his brother D K Suresh. “Let them take out route march, we don’t care,” he said.

“We all know what the BJP did during the Lok Sabha elections, and the media reported how much money they spent in the elections. What was the Election Commission doing? Was the Income Tax Department sitting with its eyes closed? Why did they conduct raids only in Hassan, Shivamogga and Mandya districts,” he asked.

He alleged that false cases were slapped when him and other leaders, including H D Kumaraswamy, Siddaramaiah, G Parameshwara and Dinesh Gundurao.

Bengaluru, May 17: At least 54 new COVID-19 positive cases have emerged since last evening, raising Karnataka's tally to 1,146, a health official said today.

Among the 1,146 cases, 611 are active and isolated in designated hospitals across the state, 497 patients got discharged and 37 died of the virus.

Of the new cases, Mandya district alone reported 22 cases, followed by 10 in Kalaburgi, 6 in Hassan, 4 in Dharward, 3 each in Kolar and Yadgir, 2 each in Dakshina Kannada and Shivamogga and 1 each in Udupi and Shivamogga.

New Cases Reported: 54
Total Active Cases: 611
Total Discharges: 497
Total Covid Deaths: 37
Death of Covid +ve patient due to Non-Covid cause: 1
Total Positive Cases: 1146

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.